These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30019835)

  • 1. Hepatic encephalopathy impacts the predictive value of the Fried Frailty Index.
    Tapper EB; Konerman M; Murphy S; Sonnenday CJ
    Am J Transplant; 2018 Oct; 18(10):2566-2570. PubMed ID: 30019835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study.
    Lai JC; Rahimi RS; Verna EC; Kappus MR; Dunn MA; McAdams-DeMarco M; Haugen CE; Volk ML; Duarte-Rojo A; Ganger DR; O'Leary JG; Dodge JL; Ladner D; Segev DL
    Gastroenterology; 2019 May; 156(6):1675-1682. PubMed ID: 30668935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization.
    Dunn MA; Josbeno DA; Tevar AD; Rachakonda V; Ganesh SR; Schmotzer AR; Kallenborn EA; Behari J; Landsittel DP; DiMartini AF; Delitto A
    Am J Gastroenterol; 2016 Dec; 111(12):1768-1775. PubMed ID: 27575708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
    Simón-Talero M; Roccarina D; Martínez J; Lampichler K; Baiges A; Low G; Llop E; Praktiknjo M; Maurer MH; Zipprich A; Triolo M; Vangrinsven G; Garcia-Martinez R; Dam A; Majumdar A; Picón C; Toth D; Darnell A; Abraldes JG; Lopez M; Kukuk G; Krag A; Bañares R; Laleman W; La Mura V; Ripoll C; Berzigotti A; Trebicka J; Calleja JL; Tandon P; Hernandez-Gea V; Reiberger T; Albillos A; Tsochatzis EA; Augustin S; Genescà J;
    Gastroenterology; 2018 May; 154(6):1694-1705.e4. PubMed ID: 29360462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study.
    Bajaj JS; Thacker LR; Heuman DM; Sterling RK; Stravitz RT; Sanyal AJ; Luketic V; Fuchs M; Gilles HC; Wade JB
    Liver Transpl; 2012 Oct; 18(10):1179-87. PubMed ID: 22674517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist.
    Sinclair M; Poltavskiy E; Dodge JL; Lai JC
    World J Gastroenterol; 2017 Feb; 23(5):899-905. PubMed ID: 28223735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis.
    Ney M; Tangri N; Dobbs B; Bajaj J; Rolfson D; Ma M; Ferguson T; Bhardwaj P; Bailey RJ; Abraldes J; Tandon P
    Am J Gastroenterol; 2018 Oct; 113(10):1506-1515. PubMed ID: 30267028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance-Based Measures Associate With Frailty in Patients With End-Stage Liver Disease.
    Lai JC; Volk ML; Strasburg D; Alexander N
    Transplantation; 2016 Dec; 100(12):2656-2660. PubMed ID: 27495749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale.
    Tandon P; Tangri N; Thomas L; Zenith L; Shaikh T; Carbonneau M; Ma M; Bailey RJ; Jayakumar S; Burak KW; Abraldes JG; Brisebois A; Ferguson T; Majumdar SR
    Am J Gastroenterol; 2016 Dec; 111(12):1759-1767. PubMed ID: 27481305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy.
    Hu XP; Gao J
    World J Gastroenterol; 2019 Jul; 25(26):3426-3437. PubMed ID: 31341366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic encephalopathy expands the predictivity of model for end-stage liver disease in liver transplant setting: Evidence by means of 2 independent cohorts.
    Lucidi C; Ginanni Corradini S; Abraldes JG; Merli M; Tandon P; Ferri F; Parlati L; Lattanzi B; Poli E; Di Gregorio V; Farcomeni A; Riggio O
    Liver Transpl; 2016 Oct; 22(10):1333-42. PubMed ID: 27434824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care.
    Bohra A; Worland T; Hui S; Terbah R; Farrell A; Robertson M
    World J Gastroenterol; 2020 May; 26(18):2221-2231. PubMed ID: 32476788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation rates.
    Kerbert AJC; Reverter E; Verbruggen L; Tieleman M; Navasa M; Mertens BJA; Rodríguez-Tajes S; de Vree M; Metselaar HJ; Chiang FWT; Verspaget HW; van Hoek B; Bosch J; Coenraad MJ
    Clin Transplant; 2018 Nov; 32(11):e13412. PubMed ID: 30230613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis.
    Saleh ZM; Solano QP; Louissaint J; Jepsen P; Tapper EB
    United European Gastroenterol J; 2021 Jul; 9(6):672-680. PubMed ID: 34102040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frailty, Psychoactive Medications, and Cognitive Dysfunction Are Associated With Poor Patient-Reported Outcomes in Cirrhosis.
    Tapper EB; Baki J; Parikh ND; Lok AS
    Hepatology; 2019 Apr; 69(4):1676-1685. PubMed ID: 30382584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Lai JC; Covinsky KE; Dodge JL; Boscardin WJ; Segev DL; Roberts JP; Feng S
    Hepatology; 2017 Aug; 66(2):564-574. PubMed ID: 28422306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.